Tangui Maurice Selected Research

Amnesia (Dissociative Amnesia)

9/2014	Neuroprotection by the synthetic neurosteroid enantiomers ent-PREGS and ent-DHEAS against Aβ₂₅₋₃₅ peptide-induced toxicity in vitro and in vivo in mice.
11/2009	The pharmacology of sigma-1 receptors.
9/2006	Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).
5/2002	Strain differences in sigma(1) receptor-mediated behaviours are related to neurosteroid levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tangui Maurice Research Topics

Disease

40	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 05/2009
10	Memory Disorders (Memory Loss) 05/2023 - 08/2002
8	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 02/2004
4	Wolfram Syndrome (Syndrome, Wolfram) 04/2024 - 01/2018
4	Neuroinflammatory Diseases 01/2023 - 07/2011
4	Amyloid Plaque 01/2023 - 07/2011
4	Inflammation (Inflammations) 01/2021 - 05/2009
4	Amnesia (Dissociative Amnesia) 09/2014 - 05/2002
4	Body Weight (Weight, Body) 01/2013 - 06/2009
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 01/2020
3	Huntington Disease (Huntington's Disease) 01/2023 - 01/2018
3	Brain Diseases (Brain Disorder) 01/2022 - 04/2007
3	Stroke (Strokes) 01/2017 - 11/2009
3	Cocaine-Related Disorders (Cocaine Addiction) 11/2009 - 05/2003
3	Mood Disorders (Mood Disorder) 06/2009 - 02/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2024 - 01/2022
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022 - 01/2020
2	Down Syndrome (Down's Syndrome) 01/2018 - 11/2015
2	Cognitive Dysfunction 01/2016 - 09/2014
2	Neuroblastoma 09/2014 - 04/2004
2	Cystinosis 06/2009 - 08/2007
2	Substance-Related Disorders (Drug Abuse) 05/2003 - 04/2002
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2024
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2023
1	Autistic Disorder (Autism) 12/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021

Drug/Important Bio-Agent (IBA)

15	Amyloid (Amyloid Fibrils)IBA 01/2023 - 07/2011
11	Neuroprotective AgentsIBA 03/2024 - 05/2009
11	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2011
11	Peptides (Polypeptides)IBA 01/2023 - 08/2002
7	LigandsIBA 01/2022 - 02/2005
6	ButyrylcholinesteraseIBA 11/2023 - 01/2018
6	Cholinergic Agents (Cholinergics)IBA 01/2023 - 08/2011
5	Sigma-1 ReceptorIBA 01/2024 - 01/2020
5	AntioxidantsIBA 01/2021 - 02/2012
4	Memantine (Namenda)FDA Link 01/2024 - 04/2004
3	CalciumIBA 04/2024 - 04/2013
3	fluoroethylnormemantineIBA 03/2024 - 01/2021
3	EnzymesIBA 01/2021 - 02/2012
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 09/2007
3	N- dimethyl- 2,2- diphenyl- 3- furanmethanamine hydrochloride tetrahydro-NIBA 01/2014 - 08/2011
3	Antidepressive Agents (Antidepressants)IBA 06/2009 - 02/2004
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2024 - 01/2023
2	CarbamatesIBA 11/2023 - 10/2019
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2023 - 01/2018
2	tau Proteins (tau Protein)IBA 01/2023 - 09/2014
2	pridopidineIBA 01/2023 - 01/2021
2	AcetylcholinesteraseIBA 08/2022 - 01/2019
2	FenfluramineIBA 01/2022 - 01/2020
2	Glial Fibrillary Acidic ProteinIBA 01/2021 - 05/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020
2	peptide AIBA 01/2019 - 08/2011
2	Erythropoietin FDA Link 01/2017 - 11/2013
2	Galantamine (Galanthamine)FDA LinkGeneric 01/2016 - 06/2006
2	SteroidsIBA 09/2014 - 06/2009
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2013 - 06/2006
2	Amyloid beta-PeptidesIBA 11/2013 - 07/2010
2	Donepezil (Aricept)FDA LinkGeneric 11/2013 - 06/2006
2	GlucocorticoidsIBA 05/2013 - 05/2003
2	Cocaine (Cocaine HCl)IBA 07/2009 - 04/2002
2	Cystine (L-Cystine)IBA 06/2009 - 08/2007
2	NeurosteroidsIBA 09/2007 - 05/2003
2	igmesineIBA 06/2006 - 05/2002
2	2- (4- morpholino)ethyl- 1- phenylcyclohexane- 1- carboxylateIBA 04/2004 - 05/2002
1	mitochondrial calcium uniporterIBA 04/2024
1	glucose-regulated proteinsIBA 04/2024
1	TungstenIBA 04/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 04/2024
1	bafilomycin A1IBA 04/2024
1	Voltage-Dependent Anion Channel 1IBA 04/2024
1	Investigational DrugsIBA 03/2024
1	Complement System Proteins (Complement)IBA 03/2024
1	Anti-Anxiety Agents (Anxiolytics)IBA 03/2024
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2024
1	Apolipoproteins E (ApoE)IBA 05/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Citric Acid (Citrate)FDA LinkGeneric 01/2023
1	Lysosomal Membrane ProteinsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	benzimidazoleIBA 08/2022
1	FlavonoidsIBA 07/2022
1	Protein SIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 12/2021
1	Cytochromes c (Cytochrome c)IBA 01/2021
1	Huntingtin ProteinIBA 01/2021
1	AmidesIBA 01/2021
1	UbiquitinIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	ferulic acid (sodium ferulate)IBA 01/2021
1	MelatoninIBA 01/2021
1	polyglutamineIBA 01/2021
1	Histone Deacetylase 6IBA 01/2021

Therapy/Procedure

6	Therapeutics 01/2023 - 07/2009